US OptionsDetailed Quotes
IFRX250117C2500
- 0.30
- -0.05-14.29%
15min DelayTrading Dec 26 13:30 ET
0.30High0.05Low
0.05Open0.35Pre Close13 Volume1.41K Open Interest2.50Strike Price90.00Turnover125.42%IV8.95%PremiumJan 17, 2025Expiry Date0.07Intrinsic Value100Multiplier22DDays to Expiry0.23Extrinsic Value100Contract SizeAmericanOptions Type0.5996Delta0.4876Gamma7.34Leverage Ratio-0.0072Theta0.0007Rho4.40Eff Leverage0.0024Vega
InflaRx Stock Discussion
1 MINUTE AGO, 7:51 AM EST
VIA GLOBENEWSWIRE
InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and Venereology Congress
InflaRx presented a post hoc analysis of the SHINE Phase 2b study of vilobelimabin hidradenitis suppurativa (HS) at the 2024 EADV Congress. The analysis focused on the 1200 mg dose, which showed significant improvements compared to placebo at 16 weeks:
- 45.2% reduction in draining tunnels
- 25.1% reduction in tot...
InflaRx to Present New Preclinical Data on INF904 at the 19th European Meeting on Complement in Human Diseases
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company focusing on anti-inflammatory therapeutics, will present preclinical data on INF904, their novel oral C5aR inhibitor, at the 2024 European Meeting on Complement in Human Diseases (EMCHD) in Lübeck, Germany, from September 2-6, 2024. The company will showcase two poster presentations, participate in a C5a/C...
InflaRx N.V., a biopharmaceutical company specializing in anti-inflammatory treatments through targeting the complement system, announced that its investigational drug GOHIBIC (vilobelimab) has been chosen by the Biomedical Advanced Research and Development Authority (BARDA). This selection places vilobelima...
NEWS
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
✅1️⃣ HOWL Long > 2.73 Short < 2.61
✅2️⃣ NVOS Long > 0.3300 Short < 0.3095
✅3️⃣ CYTO Long > 0.2035 Short < 0.1855
✅4️⃣ PSTV Long > 1.64 Short < 1.49
✅5️⃣ IFRX Long > 1.62 Short < 1.53
✅6️⃣ FUBO Long > 3.20 Short < 2.99
No comment yet